Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators

University of Washington, Seattle, USA.

OBJECTIVES: The purpose of this study was to prospectively examine in a multicenter study the methods of use, efficacy and complications of a unipolar cardioverter-defibrillator in patients at risk for sudden cardiac death. BACKGROUND: Implantation of cardioverter-defibrillators in the pectoral region offers a significant opportunity to improve the management of patients with life-threatening arrhythmias. Unipolar, single-lead, pectoral implantable cardioverter-defibrillators might decrease related mortality, morbidity and costs in the care of such patients. METHODS: From November 3, 1993 to May 8, 1995, a unipolar defibrillator (Medtronic model 7219C) was selected for use in 473 patients from 74 centers (386 [82%] men, 87 [18%] women; mean [+/- SD] age 59 +/- 13 years, range 16 to 88). The clinical indication for use was ventricular fibrillation in 157 patients, sustained ventricular tachycardia in 236, both ventricular tachycardia and ventricular fibrillation in 53 and syncope or inducible ventricular tachycardia/ventricular fibrillation in 27. Coronary artery disease was present in 323 patients (68%). The mean left ventricular ejection fraction was 0.36 +/- 0.15 (range 0.10 to 0.85). The distribution of New York Heart Association congestive heart failure was class I = 34%; class II = 45%; class III = 17%; and class IV = 2%. RESULTS: The unipolar cardioverter-defibrillator was inserted successfully in 464 (98%) of 473 candidates. Effective defibrillation occurred with the first shock polarity tested in 88% of patients, after a polarity switch in 8% and after lead or generator repositioning in 2%. The stored energy defibrillation threshold was obtained at implantation in 339 patients (72%) and was 11.5 +/- 6.1 J, with 72% of patients having a defibrillation threshold < or = 12 J. The mean "skin-to-skin" implantation time was 96 +/- 45 min (range 25 to 335 min). Complications occurred in 29 patients (6%). Device therapy for 2,160 spontaneous ventricular tachycardia or fibrillation episodes occurred in 128 patients (27%) over a 2,732 device-month experience (range 0 to 17.2) and was effective in 98.7% of episodes. There were 14 deaths (10 nonsudden cardiac, 3 sudden cardiac, 1 noncardiac). Cumulative survival, on an intention-to-treat basis from all causes of death at 17.2 months, was 94.4%. CONCLUSIONS: Unipolar pectoral implantable cardioverter-defibrillators can be inserted with a high likelihood of success in a relatively brief procedure. Defibrillation thresholds are low, morbidity is modest, and survival rates are good with this new type of implantable cardioverter-defibrillator.

This article has been cited by other articles:

				B. Lemke, T. Lawo, M. Zarse, A. Lubinski, U. Kreutzer, J. Mueller, A. Schuchert, S. Mitzenheim, D. Danilovic, T. Deneke, et al. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol Europace, August 1, 2008; 10(8): 907 - 913. [Abstract] [Full Text] [PDF]

				K. A. Ellenbogen, M. A. Wood, R. K. Shepard, H. F. Clemo, T. Vaughn, K. Holloman, M. Dow, J. Leffler, A. Abeyratne, and D. Verness Detection and management of animplantable cardioverter defibrillator lead failure: Incidence and clinical implications J. Am. Coll. Cardiol., January 1, 2003; 41(1): 73 - 80. [Abstract] [Full Text] [PDF]

				Committee Members, G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1703 - 1719. [Full Text] [PDF]

				G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, M. J. Silka, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation, October 15, 2002; 106(16): 2145 - 2161. [Full Text] [PDF]

				F. A. L. E. Bracke, A. Meijer, and L. M. van Gelder Malfunction of endocardial defibrillator leads and lead extraction: where do they meet? Europace, January 1, 2002; 4(1): 19 - 24. [Full Text] [PDF]

				C. D. Swerdlow Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation Circulation, May 1, 2001; 103(17): 2159 - 2164. [Abstract] [Full Text] [PDF]

				M. H. Gollob and J. J. Seger Current Status of the Implantable Cardioverter-Defibrillator Chest, April 1, 2001; 119(4): 1210 - 1221. [Abstract] [Full Text] [PDF]

				B. Schulte, J. Sperzel, J. Carlsson, T. Schwarz, W. Ehrlich, H. F. Pitschner, and J. Neuzner Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements Europace, January 1, 2001; 3(3): 177 - 180. [Abstract] [PDF]

				K. Glatter and L. B. Liem Implantable Cardioverter Defibrillator: Current Progress and Management Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 162 - 179. [Abstract] [PDF]

				M. Greene, D. Newman, M. Geist, M. Paquette, D. Heng, and P. Dorian Is electrical storm in ICD patients the sign of a dying heart?: Outcome of patients with clusters of ventricular tachyarrhythmias Europace, January 1, 2000; 2(3): 263 - 269. [Abstract] [PDF]

				J. P Causer and D. T Connelly Implantable defibrillators for life threatening ventricular arrhythmias BMJ, September 19, 1998; 317(7161): 762 - 763. [Full Text] [PDF]

				Y. Yamanouchi, K. A. Mowrey, M. J. Niebauer, P. J. Tchou, and B. L. Wilkoff Additional Lead Improves Defibrillation Efficacy With an Abdominal `Hot Can' Electrode System Circulation, December 16, 1997; 96(12): 4400 - 4407. [Abstract] [Full Text]

				C. D. Swerdlow, J. E. Brewer, R. M. Kass, and M. W. Kroll Application of Models of Defibrillation to Human Defibrillation Data : Implications for Optimizing Implantable Defibrillator Capacitance Circulation, November 4, 1997; 96(9): 2813 - 2822. [Abstract] [Full Text]

				C. D. Swerdlow, C. T. Peter, R. M. Kass, E. S. Gang, W. J. Mandel, C. Hwang, D. J. Martin, and P.-S. Chen Programming of Implantable Cardioverter-Defibrillators on the Basis of the Upper Limit of Vulnerability Circulation, March 18, 1997; 95(6): 1497 - 1504. [Abstract] [Full Text]